share_log
Reuters ·  Apr 25 18:30

Apr 25 (Reuters) - Edwards Lifesciences Q1 Adjusted Gross Margin 76%.

  • Q1 Adjusted Free Cash Flow USD 206 Million
  • Q1 Sales USD 1,600 Million Vs. Ibes Estimate USD 1,569 Million
  • Q1 EPS USD 0.58
  • Outlook FY Adjusted EPS USD 2.7-2.8
  • Outlook FY Sales USD 320-340 Million
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment